TL;DR
This study investigates the prevalence and genetic makeup of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in Hunan and Hebei provinces, China, revealing widespread infection, particularly in diseased pigs. The research highlights the dominance of NADC30-like (sublineage 1.8) and highly pathogenic PRRSV (HP-PRRSV, sublineage 8.7) strains, and importantly, identifies a novel recombinant strain, offering crucial insights for future PRRSV control strategies.
What Problem Does This Paper Address?
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is a major economic threat to the global swine industry, causing significant losses due to reproductive failures and respiratory distress in pigs. While PRRSV has been a persistent problem in China, the landscape of its prevalence and genetic diversity has been evolving, especially in the wake of the African Swine Fever (ASF) outbreak which may have impacted biosecurity measures and vaccination practices. Understanding the current epidemiological situation and the genetic characteristics of circulating PRRSV strains is crucial for developing effective prevention and control strategies. This paper aims to fill this gap by providing an updated assessment of PRRSV in two key Chinese provinces, Hunan and Hebei, focusing on both serological and molecular aspects.
Methods
The researchers employed a multi-pronged approach:
- Serological Investigation: Enzyme-linked immunosorbent assay (ELISA) was used to detect PRRSV-specific antibodies in serum samples from a large cohort of pigs. This provides a broad overview of exposure within the pig population.
- Molecular Detection: Real-time quantitative PCR (qPCR) was utilized to detect the presence of PRRSV nucleic acids in tissue samples. This method allows for the identification of active infections.
- Virus Isolation and Sequencing: PRRSV-positive samples with low Ct values were used for virus isolation in Marc-145 cells. The ORF5 gene, a commonly used marker for PRRSV genetic analysis due to its variability, was amplified and sequenced from 43 field isolates.
- Phylogenetic Analysis: The obtained ORF5 gene sequences were aligned with reference strains to construct phylogenetic trees using the neighbor-joining method. This helps in classifying the isolates into known lineages and sublineages and understanding their evolutionary relationships.
- Recombination Analysis: For four isolated strains, complete genome sequences were obtained. SimPlot software was used to analyze these genomes for potential recombination events between different PRRSV strains.
Datasets
The study utilized two main types of datasets:
- Serum Samples: 4007 serum samples were collected from pigs across Hunan (n=2072) and Hebei (n=1935) provinces between March and November 2021. These pigs had varying development stages (gilts, sows, fattening pigs, nursing pigs) and were previously immunized with commercial PRRSV vaccines.
- Tissue Samples: A total of 5799 tissue samples (tonsils, lymph nodes, lungs) were collected from clinically healthy pigs in farms and slaughterhouses, as well as from diseased pigs with suspected PRRS symptoms, and from non-hazardous disposal sites in Hunan and Hebei provinces.
- Reference Strains: 21 reference PRRSV strains were included in the phylogenetic analysis to compare and classify the newly identified isolates.
Key Insights and Ideas
- Ubiquitous PRRSV Presence: The study confirms that PRRSV remains a significant and widespread pathogen in China, with a high seroprevalence across both surveyed provinces.
- Diseased Pigs as Key Indicators: The significantly higher detection rates of PRRSV in diseased pigs compared to healthy ones underscores the diagnostic importance of clinical signs and the role of sick animals in viral shedding and transmission.
- Dominance of Specific Sublineages: The research clearly identifies sublineage 1.8 (NADC30-like) and sublineage 8.7 (HP-PRRSV) as the predominant circulating strains, providing critical information for vaccine development and targeted control efforts.
- Co-circulation and Recombination: The observation of multiple PRRSV lineages circulating within the same pig farms and the identification of a novel recombinant strain (HuN-XT-B) highlight the dynamic nature of PRRSV evolution and the potential for new, potentially more virulent, strains to emerge through recombination.
- Implications for Biosecurity and Vaccines: The findings suggest that enhanced biosecurity measures are paramount, and the development of novel, highly effective vaccines is needed, especially given the potential for poor cross-protection against emerging strains like NADC30-like variants.
Key Results
- Seroprevalence: 73.12% (2930/4007) of serum samples tested positive for PRRSV antibodies. The seropositive rate was higher in Hebei province than in Hunan province. Sows and gilts showed higher antibody positivity rates than nursing and fattening pigs.
- Molecular Detection: 8.31% (482/5799) of tissue samples tested positive for PRRSV nucleic acids. Diseased pigs exhibited a significantly higher positive rate (27.82%) compared to healthy pigs in farms (2.70%) and slaughterhouses (7.70%).
- Phylogenetic Classification: Of the 43 PRRSV strains analyzed, 24 belonged to lineage 1 (with 22 in sublineage 1.8), 15 to lineage 8 (with 12 in sublineage 8.7), and 4 to lineage 3.
- Novel Recombinant Strain: A novel strain, HuN-XT-B, was identified as a recombinant between NADC30-like and JXA1 (or MLV-like) strains, with recombination breakpoints identified in the ORF1a and ORF1b genes.
Limitations and Future Work
- ELISA Limitations: The study acknowledges that ELISA, while useful for seroprevalence, cannot differentiate between field PRRSV infection and vaccination, necessitating further investigation to confirm field strain prevalence in vaccinated pigs.
- Recombinant Strain Virulence: While a novel recombinant strain was identified, its specific virulence and impact on pig health require further experimental investigation.
- Future Research Directions: The authors suggest that future research should focus on the virulence of newly identified strains, including the recombinant one, and investigate the roles of specific amino acid substitutions in the GP5 protein in viral characteristics like virulence, replication, and immunogenicity. Further studies on the development of safer and more effective vaccines are also recommended.
Summary updated